CAS
BNGO icon

CTC Alternative Strategies’s Bionano Genomics BNGO Stock Holding History

CTC Alternative Strategies’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-44
Closed -$16.2K – 93
2023
Q2 		$16.2K Buy
+44
New +$19.9K 0.02% 150

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CTC Alternative Strategies's BNGO Position: Q3 2023 in Review

CTC Alternative Strategies sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 44 shares — an estimated $16.2K sold.

CTC Alternative Strategies first reported a position in BNGO in Q2 2023 and held it in 1 quarter. The position peaked at $16.2K in Q2 2023. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • CTC Alternative Strategies reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • CTC Alternative Strategies sold 44 Bionano Genomics shares in Q3 2023, an estimated $16.2K.
  • CTC Alternative Strategies first reported a position in Bionano Genomics in Q2 2023 and held it in 1 quarter.
  • CTC Alternative Strategies's Bionano Genomics position peaked at $16.2K in Q2 2023.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on CTC Alternative Strategies's 13F filing for Q3 2023, filed 31 Oct 2023.